Cannabis Bioscience International Holdings (CBIH) Stock Statistics & Valuation Metrics
Total Valuation
Cannabis Bioscience International Holdings has a market cap or net worth of $2.44M. The enterprise value is $3.89T.
- Market Cap
- $2.44M
- Enterprise Value
- $3.89T
Share Statistics
Cannabis Bioscience International Holdings has 12,214,160,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 12,214,160,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Cannabis Bioscience International Holdings’s return on equity (ROE) is 0.47 and return on invested capital (ROIC) is 56.68%.
- Return on Equity (ROE)
- 0.47
- Return on Assets (ROA)
- -17.22
- Return on Invested Capital (ROIC)
- 56.68%
- Return on Capital Employed (ROCE)
- 0.46
- Revenue Per Employee
- 151.51K
- Profits Per Employee
- -274.41K
- Employee Count
- 2
- Asset Turnover
- 9.51
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Cannabis Bioscience International Holdings is -0.01. Cannabis Bioscience International Holdings’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 18.81
- PB Ratio
- -1.58
- Price to FCF
- -9.54
- Price to Operating Cash Flow
- -9.54
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Cannabis Bioscience International Holdings had revenue of 303.02K and earned -548.82K in profits. Earnings per share was -0.05.
- Revenue
- 303.02K
- Gross Profit
- 262.92K
- Operating Income
- -421.37K
- Pretax Income
- -548.82K
- Net Income
- -548.82K
- EBITDA
- -335.53K
- Earnings Per Share (EPS)
- -0.05
Cash Flow
In the last 12 months, operating cash flow was -243.78K and capital expenditures -5, giving a free cash flow of -243.78K billion.
- Operating Cash Flow
- -243.78K
- Free Cash Flow
- -243.78K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Cannabis Bioscience International Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.48%
- Earnings Yield
- -22.16%
Stock Price Statistics
- Beta
- -0.98
- 52-Week Price Change
- -52.17%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Cannabis Bioscience International Holdings as a current ratio of 0.03, with Debt / Equity ratio of -36.12%
- Current Ratio
- 0.03
- Quick Ratio
- 0.03
- Debt to Market Cap
- 64.59
- Net Debt to EBITDA
- -1.21
- Interest Coverage Ratio
- -2.34
Taxes
In the past 12 months, Cannabis Bioscience International Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Cannabis Bioscience International Holdings EV to EBITDA ratio is -9.00, with an EV/FCF ratio of -11.20.
- EV to Sales
- 22.09
- EV to EBITDA
- -9.00
- EV to Free Cash Flow
- -11.20
- EV to Operating Cash Flow
- -11.20
Balance Sheet
Cannabis Bioscience International Holdings has $90.00 in cash and marketable securities with $406.14K in debt, giving a net cash position of -$406.05K billion.
- Cash & Marketable Securities
- $90.00
- Total Debt
- $406.14K
- Net Cash
- -$406.05K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is -0.06%, with operating margin of -312.80%, and net profit margin of -416.81%.
- Gross Margin
- -0.06%
- Operating Margin
- -312.80%
- Pretax Margin
- -416.97%
- Net Profit Margin
- -416.81%
- EBITDA Margin
- -245.55%
- EBIT Margin
- -252.26%
Analyst Forecast
The average price target for Cannabis Bioscience International Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -64.05%
- EPS Growth Forecast
- ―